Sterne Agee Tweaks BBBY Estimates

Sterne Agee is tweaking its Bed Bath & Beyond Inc. BBBY estimate for Q4 to $0.96 from $0.93 with slightly higher sales and lower SG&A, “which brings our estimate for the full year to $2.91 from $2.79.” Additionally Sterne Agee is raising its estimates for FY11 and FY12 to $3.21 and $3.50, respectively, from $3.04 and $3.41 previously, primarily reflecting a lower share count. Bed Bath & Beyond closed Wednesday at $47.67.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst RatingsBed Bath & BeyondConsumer DiscretionaryHomefurnishing RetailSterne Agee
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!